Vaxart's Quarterly Earnings: What to Expect Next

Author: Olivia Taylor Updated: 08-12-2025 03:29 PM

Upcoming Earnings Report for Vaxart

Vaxart VXRT is prepared to share its quarterly earnings report soon. Investors are looking forward to the announcement, anticipated on a Wednesday. This report is seen as crucial for evaluating the current standing and future expectations of the company.

Analysts' Expectations

Currently, analysts predict that Vaxart will report earnings per share (EPS) of approximately $-0.10. This level of expectation sets the stage for scrutiny as Vaxart approaches the release date. Investors are particularly eager to see whether the company can surpass these estimates.

The Importance of Guidance

For those unfamiliar, company guidance represents forward-looking statements about expected performance. Such forecasts can significantly influence stock price movements. Consequently, investors are also keen to hear Vaxart's future expectations during the earnings call.

Review of Historical Earnings

When reviewing Vaxart's previous earnings reports, it's notable that the last quarter saw the company miss its estimates by $0.00, resulting in a 3.73% decline in share price the subsequent day. This missed estimate showcases the volatility often associated with biotechnology stocks.

Vaxart’s Performance Snapshot

Both investors and analysts closely analyze historical data to gauge potential movements. Here’s a summary of recent performances:

Quarter       | EPS Estimate | EPS Actual | Price Change % 
--------------|--------------|------------|-----------------
Q1 2025      | -0.07        | -0.07      | -4.0% 
Q4 2024      | -0.11        | -0.04      | -9.0% 
Q3 2024      | -0.10        | -0.06      | -12.0%  
Q2 2024      | -0.03        | -0.09      | -8.0%

Current Stock Performance

As of recent trading sessions, the shares of Vaxart are priced at $0.32. Looking back over the past year, Vaxart has experienced a notable decline of 38.04% in its stock price. This drop may contribute to the apprehension felt by long-term shareholders leading into the upcoming earnings release.

Investor Sentiment and Market Context

Amid these metrics, investors should remain cautious. The overall sentiment in the biotech sector is often driven by innovation prospects, regulatory updates, and product pipeline advancements. While Vaxart’s recent performance reflects struggle, future announcements could signal shifts that are pivotal for stock recoveries.

Frequently Asked Questions

What is Vaxart's scheduled date for releasing earnings?

Vaxart is set to announce its earnings report soon, and traders will hold their breath for the figures.

What do analysts expect for Vaxart's EPS?

Analysts anticipate an EPS of $-0.10 for Vaxart.

How did Vaxart perform in the last earnings report?

In the previous quarter, Vaxart missed earnings estimates, leading to a decline in share value.

What impact can guidance have on Vaxart's stock?

Company guidance affects investor expectations and can lead to significant price changes.

How has Vaxart's stock performed over the past year?

Vaxart's stock price has decreased by 38.04% over the last 52 weeks, reflecting challenges faced by the company.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.